R Squared Ltd Acquires New Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

R Squared Ltd acquired a new stake in LifeStance Health Group, Inc. (NASDAQ:LFSTFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 10,900 shares of the company’s stock, valued at approximately $80,000.

A number of other hedge funds have also added to or reduced their stakes in LFST. Dimensional Fund Advisors LP increased its stake in LifeStance Health Group by 82.0% in the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock valued at $4,991,000 after acquiring an additional 457,930 shares during the last quarter. Sei Investments Co. bought a new stake in shares of LifeStance Health Group during the second quarter worth $477,000. Squarepoint Ops LLC grew its stake in shares of LifeStance Health Group by 115.6% during the second quarter. Squarepoint Ops LLC now owns 75,296 shares of the company’s stock worth $370,000 after buying an additional 40,369 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of LifeStance Health Group by 14.1% during the second quarter. The Manufacturers Life Insurance Company now owns 73,943 shares of the company’s stock worth $363,000 after buying an additional 9,156 shares during the last quarter. Finally, Algert Global LLC bought a new stake in shares of LifeStance Health Group during the second quarter worth $57,000. 85.50% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on LFST. Barclays boosted their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a research note on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $8.70.

Check Out Our Latest Stock Analysis on LFST

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $7.97 on Friday. The firm has a market cap of $3.05 billion, a PE ratio of -30.65 and a beta of 1.26. The firm’s fifty day moving average is $7.59 and its 200-day moving average is $6.90. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group, Inc. has a 52 week low of $4.64 and a 52 week high of $9.20.

LifeStance Health Group (NASDAQ:LFSTGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.05. The company had revenue of $312.70 million for the quarter, compared to analyst estimates of $302.25 million. LifeStance Health Group had a negative net margin of 7.90% and a negative return on equity of 6.66%. LifeStance Health Group’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.17) earnings per share. Sell-side analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

Insider Activity at LifeStance Health Group

In related news, Director Robert Bessler sold 75,000 shares of the business’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the transaction, the director now owns 1,424,447 shares in the company, valued at $10,740,330.38. The trade was a 5.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 6.60% of the stock is owned by company insiders.

About LifeStance Health Group

(Free Report)

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Recommended Stories

Institutional Ownership by Quarter for LifeStance Health Group (NASDAQ:LFST)

Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.